|
|
||||||||
Department of Biochemistry, and Institute of Life Science and Biotechnology, College of Science, Yonsei University, Seoul 120-749, Korea
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The regulation of the mitotic exit is best characterized in budding yeast. In this organism, mitotic exit involves a collection of genes known as the mitotic exit network (MEN) that includes TEM1, CDC15, LTE1, MOB1, DBF2, CDC5, and CDC14. These genes trigger mitotic exit once anaphase has been completed (Jaspersen et al. 1999; Morgan 1999; McCollum & Gould 2001). When mitotic exit has been triggered by an as yet unknown mechanism, the small GTPase Tem1p activates the protein kinase Cdc15p (Asakawa et al. 2001; Lee et al. 2001), which ultimately leads to the release of the protein phosphatase Cdc14p from the nucleolus (Visintin et al. 1999; Bardin et al. 2000). Cdc14p dephosphorylates the Cdh1/Hct1 protein of the anaphase-promoting complex (APC), which then becomes active and degrades Clb2p to inactivate the Clb2-Cdc28 complex (Schwab et al. 1997; Visintin et al. 1998; Zachariae et al. 1998; Jaspersen et al. 1999). The released Cdc14p also dephosphorylates and stabilizes the Clb2-Cdc28 inhibitor Sic1p and its transcription factor Swi5p, thereby promoting Clb2-Cdc28 inactivation (Knapp et al. 1996; Visintin et al. 1998). Thus, the regulation of Tem1p is important in the mitotic exit pathway, although it is not clear at the molecular level how the exit from mitosis is triggered.
It has been suggested that GTPase Tem1p is controlled both by the guanine nucleotide exchange factor (GEF) Lte1p and the two component GTPase-activating protein (GAP) complex Bub2p-Bfa1p (Morgan et al. 1999; Hoyt 2000). The GAP activity of Bub2p-Bfa1p was first inferred from work with Schizosaccharomyce pombe. byr4p and cdc16p of S. pombe are homologues of Bfa1p and Bub2p and form a two-component GAP for the GTPase activity of a Tem1p homologue, spg1p, in vitro (Furge et al. 1998). A recent report has shown that Bfa1p and Bub2p also act as a two-component GAP for Tem1p activity in vitro (Geymonat et al. 2002). Tem1p binds Bfa1p and Bub2p on the cytoplasmic side of the spindle pole body (SPB) whereas Lte1p is associated with the cortex of the bud (Bardin et al. 2000; Pereira et al. 2000). This spatial separation of the elements regulating Tem1p activity suggests that Tem1p remains inactive in its GDP-bound form by Bub2p-Bfa1p at the SPB during most of the cell cycle and that Lte1p converts Tem1p to the GTP-bound active form when the SPB enters the daughter cell at the execution of anaphase (Bardin et al. 2000; Pereira et al. 2000).
Bfa1p and Bub2p prevent the untimely activation of mitotic exit in the absence of proper nuclear division by monitoring defects in the migration of the SPB into the bud, as well as monitoring for astral microtubule structures and DNA damage (Bloecher et al. 2000; Wang et al. 2000; Pereira et al. 2001). These data suggest that Bfa1p and Bub2p function as a universal checkpoint in response to various checkpoint signals to avoid improper mitotic exit. The phosphorylation of Bfa1p by the polo-like kinase Cdc5p antagonizes the ability of Bfa1p to permit mitotic exit (Hu et al. 2001; Geymonat et al. 2003). However, it is still not well understood how different mitotic checkpoint signals are integrated into Bfa1p and Bub2p for the regulation of Tem1p. In addition, deletion of LTE1 has little effect on the timing of mitotic exit at 30 °C, and several mutant cells in which the SPB does not migrate into bud or the neck can exit mitosis inappropriately to produce binucleated and anucleated cells, suggesting that the proposed model does not fully explain the mechanism of Tem1p regulation (Adames et al. 2001). Recently, Bfa1p was shown to regulate Tem1p to control mitotic exit in the absence of Bub2p (Ro et al. 2002). These data strongly suggest that Bfa1p is a key regulator of Tem1p in response to various mitotic checkpoint signals and that it may regulate Tem1p by an additional mechanism apart from its activity in the two-component GAP with Bub2p.
In this study, we examined the functional domains of Bfa1p that respond to several distinct checkpoint signals by analysing 13 Bfa1p deletion mutants. We show that the function of Bfa1p for mitotic arrest is concentrated on its C-terminal 184 residues. Our mutagenesis study of the C-terminal 184 residues also suggest that Bfa1p localization to the SPB is necessary but not sufficient to induce mitotic arrest in response to the checkpoint-activating signals.
| Results |
|---|
|
|
|---|
is defective in reacting to these checkpoint-activating damages and continues the cell cycle, resulting in re-budding and a sharp decrease in viability. To delineate the functional domains of Bfa1p that negatively regulate mitotic exit in response to diverse checkpoint signals, we constructed 13 Bfa1 deletion mutants and examined the ability of each mutant to induce mitotic arrest by checkpoint-activating signals, as summarized in Fig. 1.
|
We first identified the domain of Bfa1p that is required for mitotic arrest by spindle damage. The 13 BFA1 deletion mutants in low copy pCEN plasmid were tested for their ability to restore the benomyl sensitivity of bfa1
cells. The expression of each truncated mutant was verified prior to the functional assays of each mutant (Fig. 2A, right panel; data not shown). The full-length BFA1, BFA1-D8391-574, and BFA1-D1302-574 that includes the residues of D8, entirely restored the benomyl sensitivity of bfa1
, but BFA1-D161-376 could not (Fig. 2A). To confirm that BFA1-D8391-574 is sufficient to induce mitotic arrest by spindle damage, we examined the prevalence of multiple buds and the viability of bfa1
cells containing each BFA1 deletion mutant when mitotic spindle formation was inhibited by nocodazole (Fig. 2B,C). Consistent with the data shown in Fig. 2A, the full-length BFA1 and D8391-574 suppressed the re-budding and cell cycle progression of nocodazole-treated bfa1
cells, while D161-376 and the vector control did not (Fig. 2B). D8391-574 also improved the viability of nocodazole-treated bfa1
cells as the full-length BFA1 (Fig. 2C).
|
double mutant lacks the mitotic arrest due to the deletion of BFA1 and proceeds with the cell cycle at the restrictive temperature, resulting in G1 and G2 DNA content (Fig. 2D). Similarly, ask1-2 bub2
also progresses the cell cycle at the restrictive temperature (Fig. 2D). We then assessed whether BFA1-D8391-574, which is sufficient to induce mitotic arrest by nocodazole, will also activate the spindle checkpoint in the ask1-2 bfa1
double mutant. We measured DNA content and found that full-length BFA1 and D8391-574 fully recovered the ability of ask1-2 bfa1
to induce mitotic arrest in response to spindle damage, while D161-376 and the vector control did not alter the cell cycle progression of ask1-2 bfa1
cells at all (Fig. 2D). These observations demonstrate that Bfa1p-D8391-574 can respond to various spindle damages including nocodazole treatment and the mutation of ASK1, indicating that this domain encompasses the spindle checkpoint functions of Bfa1p in response to diverse spindle damages. Bfa1-D8391-574 is sufficient to induce mitotic arrest by spindle misorientation
Bfa1p prevents mitotic exit when the mitotic spindle is misoriented by a defect in the pathways that have been reported to orientate the spindle into the neck (Bloecher et al. 2000; Pereira et al. 2001; J. Kim and K. Song, unpublished observation). They are two partially redundant mechanisms, namely, the dynein/dynactin-dependent sliding of microtubules along the bud cortex, and the Kar9p- and Bim1p-dependent capture of microtubules at the bud cortex (Adames et al. 2001; Korinek et al. 2000). When BFA1 was missing, bim1
or kar9
cells show reduced survival at 23 °C, and die at 37 °C suggesting that BFA1 is important for the survival of cells with astral microtubule defects (Pereira et al. 2001). In addition, dyn1
bfa1
and dyn1
bub2
double mutant cells progress with mitosis, while, in contrast, dyn1
cells are arrested at mitosis (Bloecher et al. 2000; J. Kim and K. Song, unpublished observaiton). Thus, we delineated the domain of Bfa1p involved in the checkpoint function of Bfa1p in response to spindle misorientation by testing the ability of the 13 BFA1 deletion mutants to rescue the lethality of bim1
bfa1
at 35 °C. Full-length BFA1, D8391-574, and D1302-574 entirely reversed the lethality of bim1
bfa1
, unlike the vector control and D161-376 (Fig. 3A). When we examined the number of cells with multiple buds and the spindle orientation in bim1
bfa1
cells transformed with D8391-574 or D161-376, we found that, like full-length BFA1, D8 suppressed the new bud formation and cell cycle progression of bim1
bfa1
, while D16 and the vector control had no such effect (Fig. 3B,C). The bim1
bfa1
cells transformed with the full BFA1 or D8391-574 were arrested in mitosis with misoriented spindles, as is bim1
, but the cells with D161-376 formed new buds despite the misaligned spindle and missegregated DNA (Fig. 3C). Thus, D8391-574 contains the checkpoint functions of Bfa1p needed for cells to survive the astral microtubule defects resulting from the deletion of BIM1.
|
bfa1
double mutant undergoes mitosis despite a misaligned spindle and therefore produces multinuclear mother cells and anucleate cells that often contain an extra bud (Fig. 3E). This cell cycle progression is more obvious when the cells are incubated at 16 °C (J. Kim and K. Song, unpublished observation). To define the domain(s) of Bfa1p that maintain(s) the checkpoint function of Bfa1p to arrest at mitosis in response to spindle misorientation induced by lack of dynein, we tested each of the 13 BFA1 deletion mutants for its ability to suppress the cell cycle progression of dyn1
bfa1
. We counted the number of anucleate and multinucleate cells and cells forming an extra bud. We found these numbers were decreased by equivalent extents in dyn1
bfa1
cells transformed with D8391-574 and full-length BFA1 (Fig. 3D). In contrast, D161-376 and the vector control were unable to arrest dyn1
bfa1
cells in mitosis (Fig. 3D,E). Thus, D8391-574 appears to encompass the domain responsible in Bfa1p for sensing and responding to a misaligned spindle and improper chromosome segregation. Bfa1-D8391-574 is sufficient to arrest mitosis in response to DNA damage
Cells with the temperature-sensitive cdc13-1 mutation accumulate single-stranded DNA at non-permissive conditions and activate the DNA-damage checkpoint (Garvik et al. 1995). Bfa1p is required to inhibit the mitotic exit in response to the DNA damage induced by cdc13-1 mutation (Wang et al. 2000; Hu et al. 2001). At the restrictive temperature, the cdc13-1 bfa1
double mutant shows re-budding and re-replication due to cell cycle progression, whereas cdc13-1 cells arrest with a large bud and fail to re-replicate (Wang et al. 2000). To delineate the domain of Bfa1p involved in DNA damage-induced mitotic arrest, the 13 BFA1 deletion mutants were transformed into cdc13-1 bfa1
cells and tested for their ability to repress the new bud formation of cdc13-1 bfa1
at the non-permissive temperature. When cells with more than one bud were counted, BFA1-D8391-574 and full-length BFA1 completely inhibited new bud formation, unlike D161-376 and the vector control (Fig. 4A,B). cdc13-1bfa1
cells transformed with D8 or full-length BFA1 arrested with an enlarged bud, verifying that D8 is able to arrest the cell cycle progression of cdc13-1bfa
(Fig. 4B). Confirming this is that when we measured DNA content, we found BFA1-D8 and full-length BFA1 arrested cdc13-1bfa1
cells with G2 DNA contents (Fig. 4C). In contrast, some cdc13-1bfa1
cells transformed with D16 or the vector control underwent re-replication and therefore showed higher a DNA content than G2 (Fig. 4C). These results demonstrate that Bfa1p-D8391-574 is sufficient to block mitotic exit in response to DNA damage.
|
Bfa1p activity in response to multiple checkpoint signals is regulated by its phosphorylation. The phosphorylation of Bfa1p by the polo-like kinase Cdc5p antagonizes the ability of Bfa1p to promote mitotic exit (Hu et al. 2001; Geymonat et al. 2003). One would expect therefore that BFA1 and CDC5 interact genetically together. Supporting this is the observation that deletion of BFA1 has been reported to rescue the mitotic exit defect of cdc5 mutant alleles. For example, the cdc5-2 mutant allele inhibits Bfa1p phosphorylation and mitotic exit at the restrictive temperature, but this phenotype is suppressed by the deletion of BFA1 (Hu et al. 2001). In addition, loss of BFA1 alleviates the mitotic exit defect of the cdc5-1 mutation, although the cdc5-1 mutant allele phosphorylates Bfa1p (Ro et al. 2002). Both the cdc5-1 and cdc5-2 mutant alleles showed a growth defect in the restrictive temperature that is suppressed in cdc5-1 bfa1
and cdc5-2 bfa1
(Fig. 5A, right panels). We tested therefore whether D8391-574 or D161-376 could reduce the growth of cdc5-1 bfa1
and cdc5-2 bfa1
cells in the restrictive temperature. cdc5-1 bfa1
and cdc5-2 bfa1
cells transformed with D8391-574 or full-length BFA1 in low copy pCEN plasmids and transferred to the non-permissive temperature showed a reappearance of the growth defects (Fig. 5A). In contrast, D161-376 and the vector control did not affect the growth of the double mutants (Fig. 5A).
|
D8391-574 and D161-376 are two independent domains that induce mitotic arrest when over-expressed
In this study we showed that D8391-574 is sufficient to arrest mitosis in response to spindle damage, spindle misorientation, and DNA damage. This domain was also sufficient to genetically interact with and to be regulated by Cdc5p. Thus, we compared the ability of each mutant to induce mitotic arrest by over-expressing it in bfa1
cells (Fig. 1) and examined whether D8391-574 is the only domain to induce mitotic arrest by over-expression. When over-expression was induced for 4 h, Bfa1-D8391-574 could arrest cells in anaphase as well as the full-length Bfa1 (Fig. 6A). In addition, Bfa1-D161-376 could induce mitotic arrest (Fig. 6A). However, the number of cells arrested in anaphase by over-expressing the mutants bearing residues 225376 was approximately 70% of D8391-574 or the full-length Bfa1 (Figs 1 and 6A). These observations indicate that D8391-574 and D161-376 are two independent domains that induce mitotic arrest when over-expressed and that D8391-574 was as capable of inducing mitotic arrest as the wild-type Bfa1p. Based on two independent functional domains for mitotic arrest as well as the differences in their ability to respond diverse checkpoint signals, Bfa1p could be bipartite into the N-terminal 376 amino acids (D161-376) and the C-terminal 184 amino acids (D8391-574).
|
It is likely that Bfa1p negatively regulates mitotic exit at least partly by associating with Bub2p to form a two component GAP. Thus, we verified the expression of Bub2p as well as the full-length Bfa1, D8, and D16, and delineated the Bub2p binding domain of Bfa1p by yeast two-hybrid and co-precipitation assays (Fig. 6C). We found that only D8391-574 interacts with Bub2p as the full-length, while D161-376 could not interact with Bub2p (Fig. 6C). This observation suggests that over-expressed D161-376 interacts with Tem1p and partially induces mitotic arrest without binding to Bub2p. To test whether the mitotic arrest resulting from D8 over-expression depends on Bub2p while D16 induce mitotic arrest regardless of Bub2p, we over-expressed D8391-574 and D161-376 in bfa1
bub2
and examined the cells in the anaphase. As expected from the binding of Bub2p to D8 but not to D16, over-expressing D8 or the vector control in the absence of BUB2 did not induce mitotic arrest but over-expression of D16 or the full BFA1 continued to partially induce mitotic arrest (Fig. 6D). These observations demonstrated that the mitotic arrest by D8 over-expression is Bub2p-dependent, while D16 over-expression induces the arrest in the absence of Bub2p.
Since both D8391-574 and D161-376 block mitotic exit by over-expression and interact with Tem1p, we also investigated whether these domains inhibit mitotic exit by binding and regulating Tem1p. Thus, we examined whether Tem1p over-expression overrides the arrest of cell growth by the over-expression of D8391-574 and D161-376. The over-expression of Tem1p was confirmed in the cells expressing full-length Bfa1, D8, and D16, respectively (Fig. 6E, lower panel). The mitotic arrest by the over-expression of D8391-574 and D161-376 as well as the full-length Bfa1p was reversed by Tem1p over-expression (Fig. 6E). These observations suggest that the inhibition of mitotic exit imposed by the over-expression of D8391-574 and D161-376 depend on Tem1p, while D8 over-expression induces the arrest in a Bub2p-dependent manner.
Considering that Cdc14p is released from the nucleolus when mitotic exit is triggered (Shou et al. 1999; Visintin et al. 1999; Bardin et al. 2000) and that Bfa1p negatively regulates mitotic exit upstream of Cdc14p, over-expression of Bfa1p should block the release of Cdc14p from the nucleolus, thereby inhibiting mitotic exit. To verify the mitotic arrest by over-expression of D8391-574 and D161-376, we also examined the block of Cdc14p release from the nucleolus. As shown in Fig. 6F, Cdc14p was confined in the nucleolus of the cells over-expressing D8391-574, D161-376, and full-length Bfa1p. In contrast, Cdc14p was spread in and out of the nucleus in cells that over-expressed the vector only. Thus, the two Bfa1p domains D8391-574 and D161-376 independently inhibit mitotic exit when they are over-expressed.
Only Bfa1-D8391-574 is necessary for Bfa1p localization to the SPB
The localization of Bfa1p to SPB has been reported to be dependent on Bub2p, and vice versa (Pereira et al. 2000). However, our observations above indicate that the two Bfa1p domains D8391-574 and D161-376 both induce mitotic arrest although only D8 interacts directly with Bub2p. Only D8 also functions to arrest mitosis in response to diverse checkpoint-activating damages. To determine whether the localization of Bfa1p to the SPB is directly correlated with its checkpoint functions, we delineated the domain in Bfa1p that drives its localization to the SPB by expressing the 13 Bfa1 deletion mutants as GFP-fusions (Figs 1 and 7A). We also verified that each Bfa1p deletion mutant tagged with GFP is expressed by performing Western blots using an anti-GFP antibody. Each deletion mutant of the expected size was detected (Fig. 7B, data not shown). Only D8391-574 as well as the full-length Bfa1 localized to the SPB, and D161-376 was not detected at the SPB (Fig. 7A). The localization of D8391-574 to the SPB was also verified using a SPB marker, Spc42p. Co-localization of D8 and Spc42p was observed in YSK40 in which YFP-tagged BFA1-D8 and CFP-tagged SPC42 were integrated in bfa1
(YSK40). Bfa1-D8 expressed under the own promoter of BFA1 was enough to localize on the SPB (Fig. 7C). Co-localization of YFP-tagged D8391-574 to the SPB with CFP-tagged Spc42p was verified in the superimposed enlarged image, as shown in Fig. 7C. Thus, D8391-574, which contains the Bub2p interacting domain, also bears the capacity of Bfa1p to localize to the SPB, suggesting that the localization of Bfa1p to the SPB is directly correlated with its ability to regulate the mitotic exit in response to various checkpoint signals. Furthermore, the observation with D16 suggests that the localization of Bfa1p to the SPB is not required to induce mitotic arrest by over-expression.
|
We have so far presented that Bfa1-D8391-574 bears the ability of Bfa1p to localize to the SPB and to regulate the mitotic exit in response to various checkpoint signals, while Bfa1-D161-376 that does not localize to the SPB cannot react to the mitotic checkpoint signals despite of its binding to Tem1p. To understand the correlation of the essential checkpoint functions of D8391-574 and its localization to the SPB, we screened the mutations of Bfa1-D8391-574 that lose the checkpoint activity and examined the localization of a checkpoint-deficient mutant. We isolated a point mutation, D8E438K, by random mutagenesis of D8 with hydroxylamine, as described in Experimental procedures. We verified the loss of checkpoint function in D8E438K by examining the restore of the benomyl sensitivity in bfa1
cells, after D8E438K was integrated in bfa1
(YSK39). Both Bfa1p-D8 and D8E438K were expressed as shown in the Western blot, but the benomyl sensitivity of bfa1
was entirely restored by BFA1-D8391-574 but not by D8E438K (Fig. 8A), demonstrating that D8E438K could not respond to spindle damage any more. Consistent with the lack of checkpoint function, D8E438K no longer arrested cells in mitosis when over-expressed (data not shown). We then examined whether Bfa1-D8E438K could localize to the SPB as D8, when expressed as a GFP-fusion. As shown in Fig. 8B, Bfa1-D8E438K as well as D8 localized to the SPB, although the efficiency of localization to SPB is slightly reduced in D8E438K. Since the localization of Bfa1p to SPB has been reported to rely on Bub2p and vice versa (Pereira et al. 2000), we also examined the interaction of Bfa1-D8E438K with Bub2p by co-precipitation. As expected from its localization to SPB, D8E438K interacted with Bub2p (Fig. 8C). Furthermore, D8E438K interacted with Tem1p despite of the loss of its checkpoint function (Fig. 8C). These observations demonstrate that the mutagenized glutamine residue is critical for the checkpoint functions of Bfa1p and strongly suggest that the localization of Bfa1p to the SPB as well as its binding to Bub2p and Tem1p are necessary but not sufficient for the essential checkpoint functions of Bfa1p.
|
| Discussion |
|---|
|
|
|---|
We showed that Bfa1-D8391-574 bears the SPB-localizing and checkpoint signal-sensing activities of Bfa1, implying that the checkpoint activities of Bfa1p contained in D8391-574 likely depend on its association with Bub2p and localization to the SPB. This possibility was further investigated by isolating a point mutant of Bfa-D8, D8E438K, which loses the checkpoint functions of D8. Despite the lack of its checkpoint functions, D8E438K could localize to the SPB and interact with Bub2p and Tem1p. These results suggest that the localization of Bfa1p to the SPB by its binding to Bub2p is a prerequisite for sensing various checkpoint signals but not sufficient for checkpoint functions. In addition, our observation that the over-expression of D8E438K no longer induced mitotic arrest but could interact with Tem1p also suggest that the binding of Bfa1-D8 to Tem1p is not enough for negatively regulating Tem1p. The residue mutated in D8E438K was not the known phosphorylation site by Cdc5p. The new mutant we isolated demonstrates that the mutagenized glutamine residue is critical for the checkpoint functions of Bfa1p, possibly by directly regulating the GAP activity of Bfa1-D8 without affecting its interaction with Bub2p and Tem1p. We are currently investigating the GAP activity of Bfa1-D8E438K.
We showed that Bfa1-D8391-574 bears the SPB-localizing and checkpoint signal-sensing activities of Bfa1 although its localization to the SPB is not enough for checkpoint functions. These results still support that the localization of Bfa1p to the SPB and its binding to Bub2p are necessary for detecting the checkpoint signals. Then, why is the localization of Bfa1p to the SPB needed for sensing the defects to activate the checkpoint? Bfa1 is best known to prevent mitotic exit by recognizing the defects in spindle alignment. Two partially redundant pathways are involved in spindle orientation: the Kar9 and Bim1 pathway and a dynein-dependent pathway (Adames & Cooper 2000; Beach et al. 2000; Korinek et al. 2000; Farkasovsky & Kuntzel 2001). Recent reports showed that Kar9, Bim1, and dynein involved in the mitotic spindle orientation are present at the SPB as well as the microtubule-plus ends, suggesting that the SPB may play direct roles in spindle positioning for proper chromosome segregation (Segal & Bloom 2001; Liakopoulos et al. 2003; Maekawa et al. 2003). Considering that both Kar9 and Bfa1 are asymmetrically loaded on to the SPB that enters the bud (Li 1999; Liakopoulos et al. 2003; Maekawa et al. 2003), Bfa1p may be involved in sensing the defects in spindle misorientation to inhibit mitotic exit at the SPB. The N-terminal 376 amino acids of Bfa1p (D161-376) did not block mitotic exit in response to diverse checkpoint signals, while it did partially arrest cells in mitosis by over-expression and physically interact with Tem1p and Cdc5p. These observations demonstrate that various checkpoint signals cannot be transmitted to D16, although at least a part of mitotic arrest activity is conserved in D16. Also, D161-376 neither interacts with Bub2p nor localizes to the SPB, consistent with the previous report that the localization of Bfa1p and Bub2p to the SPB is interdependent (Pereira et al. 2000). As predicted from the lack of interaction between D16 and Bub2p, over-expression of D16 partially arrested cells in mitosis regardless of Bub2p, indicating that Bfa1p can regulate mitotic exit to some extent in the absence of Bub2p. These observations are consistent with the recent report showing that over-expression of Bfa1p efficiently arrests cell cycle at postanaphase in the absence of BUB2 and that Bfa1p can bind strongly with Tem1p independently of Bub2p (Ro et al. 2002). In addition, our data showed that mitotic arrest by Bfa1-D16 over-expression was relieved by concomitant over-expression of Tem1p. These observations strongly suggest that the mechanism that Bfa1p regulates Tem1p independent of Bub2p in the mitotic exit network as reported by Ro et al. (2002) is likely mediated by Bfa1-D16. Our data along with those of others suggest that Bfa1p acts not only in a two-component GAP with Bub2p at the SPB, it may also directly prevent Tem1p from binding with its effector(s) through D16, thereby inhibiting mitotic exit, when over-expressed. Over-expression of D16 was approximately 30% less efficient in preventing mitotic exit than D8 or full-length Bfa1p. Such lesser mitotic arrest by D16 could be ascribed to its lack of localization to the SPB and/or its poorer binding to Tem1p.
Hu et al. (2001) has shown that Bfa1p is inactivated by Cdc5p-dependent phosphorylations at 11 sites to trigger mitotic exit. The Bfa1 deletion mutants D161-376 contain nine of these phosphorylation sites while D8391-574 bears two. The mitotic exit defects of the CDC5 mutant alleles cdc5-1 and cdc5-2 are suppressed by deletion of BFA1 but were regained when D8391-574 was expressed. These two observations suggest that of the 11 Cdc5p-dependent phosphorylation sites, only the two sites mapped in D8391-574 are essential for the regulation of Bfa1p. However, when we examined a mutant D8391-574 protein containing point mutations at these two Cdc5p-dependent phosphorylation sites, we found that this protein also localized to SPB and arrested mitotic exit by over-expression (J. Kim and K. Song, unpublished observation). Thus, Bfa1p localization to the SPB is not affected by these mutations. The observation that a mutant D8391-574 protein containing point mutations at the residues phosphorylated by Cdc5p arrests mitotic exit when over-expressed is not surprising, however, since these phosphorylation sites are reported to negatively regulate Bfa1p. The loss of phosphorylation by mutations would block mitotic exit even if this protein were not over-expressed. Consistent with our results, a recent report showed that the phosphorylation of Bfa1p by Cdc5p reduces GAP activity with Bub2p (Geymonat et al. 2003).
In summary, we have shown that the major checkpoint functions of Bfa1p are concentrated in its C-terminal 184 residues and this C-terminal domain of Bfa1p is essential to respond to diverse checkpoint-activating signals. Given that our experiments did not reveal any functional discrepancies between the full-length Bfa1p and Bfa1-D8 in regulating mitotic checkpoint, the specific function of the N-terminal Bfa1p (Bfa1-D16) remains to be solved. Further studies on the interplay of Bfa1p with the proteins functioning in the spindle alignment, and the identification of the proteins that selectively interact with each Bfa1p domain will help to understand exactly how Bfa1p participates in the control of mitotic exit.
| Experimental procedures |
|---|
|
|
|---|
The S. cerevisiae strains used in this study are listed in Table 1. Yeast cells were grown in YPDA medium (1% yeast extract, 2% bactopeptone, 2% glucose and 100 µg/mL adenine) or in synthetic complete (SC) drop-out media prepared with yeast nitrogen base (YNB) and the necessary supplements. To induce expression from the GAL10-1 promoter, cells grown to mid-log in 2% glucose were transferred to SC drop-out media with 2% raffinose for 14 h and then incubated in 2% raffinose/galactose for 4 h at 30 °C. Cells were synchronized by adding
-factor (Sigma) to a final concentration of 15 µg/mL or 0.2 M hydroxyurea (Sigma) for 34 h. The cells were released from cell cycle arrest by washing the cultures with fresh medium several times. Yeast strains were constructed using a PCR-based one-step gene disruption technique previously described (Longtine et al. 1998).
|
DNA cloning and manipulation were performed using standard methods (Sambrook & Russell 2001). BFA1 deletion mutants were amplified by PCR using W303 chromosomal DNA as a template and the indicated oligonucleotides as primers (Table 2). PCR-amplified BFA1 deletion mutants were subcloned into pCEN-PGAL, pCEN-PGAL-GFP, pCEN-PBFA1 and pLexA202 +PL as described in Table 3. Each deletion mutant was inserted into pCEN-PGAL (a CEN-based vector with the GAL10-1 promoter) to observe the over-expression phenotypes. To investigate the localization of the Bfa1 deletion mutants, each mutant was subcloned into pCEN-PGAL-GFP (a pRS316-based C-terminal GFP-tagging vector with the GAL10-1 promoter). To assess the ability of Bfa1 deletion mutants to complement bfa1
, pCEN-PBFA1-BFA1 deletion mutants were constructed. The putative BFA1 promoter (about 500 bp upstream of open reading frame of BFA1) was PCR-amplified using oligonucleotides KS192 and KS193 and subcloned into pTS903CL (a CEN-based C-terminal 2 x HA and 6 x HIS epitope-tagging vector, a gift from A. Toh-e). Each PCR-amplified BFA1 deletion mutant was then inserted into pTS903CL-PBFA1. The pLexA202 +PL-BFA1 deletion mutants were constructed for two-hybrid assays. The putative BFA1 promoter (oligonucleotides KS192 and KS193) and BFA1-D8 or D8E438K (oligonucleotides KS162 and KS8) were amplified by PCR and subcloned into pRS306 to construct pRS306-PBFA1-BFA1-D8-3HA or D8E438K. pRS306-PBFA1-BFA1-D8-3HA or D8E438K were integrated into the chromosome of bfa1
(YSK8) to make strains YSK38 and YSK39. BFA1-D8-YFP SPC42-CFP bfa1
(YSK40) was constructed by the C-terminal genomic insertion of CFP into SPC42 using pDH3 (provided by Yeast Resource Center, University of Washington) and the integration of pRS304-PBFA1-BFA1-D8-YFP into bfa1
(YSK8).
|
|
For fluorescence microscopy, cells were fixed in 70% ethanol or 3.7% formaldehyde, washed twice with PBS, briefly sonicated, and mounted with 1 µg/mL 4'6-diamidino-2-phenylindole (DAPI). Cells were observed with a 100X objective on an Axioplan2 (Zeiss) and images were captured with an Axiocam CCD (Zeiss) camera using AxioVision software (Zeiss). The DNA content of cells was examined by flow cytometry as described in Hwang & Song (2002). For each sample, 20 000 cells were analysed with a Becton Dickinson fluorescence-activated cell analyser.
Two-hybrid analyses
Two-hybrid assays were performed using a system described by Gyuris et al. (1993). BUB2, TEM1, and CDC5 were subcloned into pJG4-5 after amplification by PCR. The full-length and 13 deletion mutants of BFA1 were fused to the DNA-binding domain in pLexA202 +PL. The yeast strain EGY48 was co-transformed with these constructs and the reporter plasmid pSH18-34. Duplicate samples of each combination were subjected to X-gal overlay assays and quantitative ß-galactosidase assays as described by Jwa & Song (1998).
Protein techniques
To prepare cell lysates for immunoblots and co-precipitations, harvested cells grown to mid-log phase were extracted in modified H-buffer [25 mM Tris-HCl (pH 7.4), 150 mM NaCl, 15 mM MgCl2, 15 mM EGTA (pH 7.5), 0.1% Triton X-100, 10% glycerol, 1 mM NaN3, 1 mM DTT, 0.5 mM phenylmethylsulphonyl fluoride (PMSF), protease inhibitor cocktail (Boeringer Mannheim)] by beadbeating (Biospec) and clarified by 14 000 r.p.m. centrifugation at 4 °C. For co-precipitation assays of Bfa1 deletion mutants with Tem1p or Bub2, GFP-tagged Bfa1 deletion mutants, and 3 x HA-tagged Tem1p and Bub2p under GAL10-1 promoter were, respectively, introduced into bfa1
(YSK8), separately expressed, and verified by immunoblots. Each lysate of separately expressed Bfa1 deletion mutants tagged with GFP and Tem1p or Bub2p tagged with 3 x HA was mixed together and purified with anti-HA antibody followed by protein A-agarose (Sigma). Co-precipitates were blotted with affinity-purified polyclonal anti-GFP (Santa Cruz) and monoclonal anti-HA (Roche), as described essentially by Hwang & Song (2002). For co-precipitation assays of Bfa1-D8E438K with Bub2p or Tem1p, 3xHA-tagged D8E438K and GST-tagged Bub2p and Tem1p under GAL10-1 promoter were, respectively, introduced into bfa1
(YSK8), separately expressed, and verified by immunoblots. Each lysate was mixed, purified with glutathione-agarose (Sigma), and co-precipitates were blotted with anti-GST (Upstate) and anti-HA (Roche) antibodies.
Random mutagenesis of plasmid DNA
Random in vitro mutagenesis was performed with hydroxylamine. Approximately 10 µg of plasmid pRS316-PBFA1-BFA1-D8 was incubated in 0.5 mL hydroxylamine solution (1 M hydroxylamine, 50 mM sodium pyrophosphate (pH 7.0), 100 mM sodium chloride, 2 mM EDTA) at 75 °C for 90 min. After the mixture had been cooled on ice, DNA was separated by gel filtration (Sephadex G-25) and the mutagenized plasmid pRS316-PBFA1-BFA1-D8 was introduced into bfa1
yeast strain (YSK8). Transformants were replica plated and screened for the loss of viability in the presence of 10 µg/mL benomyl. Screened mutant plasmids were restored, sequenced, and re-subcloned into the intact pRS306-PBFA1-3HA for verifying the sensitivity to benomyl.
| Acknowledgements |
|---|
| Footnotes |
|---|
* Correspondence: E-mail: bc5012{at}yonsei.ac.kr
| References |
|---|
|
|
|---|
Adames, N.R., Oberle, J.R. & Cooper, J.A. (2001) The surveillance mechanism of the spindle position checkpoint in yeast. J. Cell Biol.
153, 159168.
Asakawa, K., Yoshida, S., Otake, F. & Toh-e, A. (2001) A novel functional domain of Cdc15 kinase is required for its interaction with Tem1 GTPase in Saccharomyces cerevisiae. Genetics
157, 14371450.
Bardin, A.J., Visintin, R. & Amon, A. (2000) A mechanism for coupling exit from mitosis to partitioning of the nucleus. Cell 102, 2131.[CrossRef][Medline]
Beach, D.L., Thibodeaux, J., Maddox, P., Yeh, E. & Bloom, K. (2000) The role of the proteins Kar9 and Myo2 in orienting the mitotic spindle of budding yeast. Curr. Biol. 10, 14971506.[CrossRef][Medline]
Bloecher, A., Venturi, G.M. & Tatchell, K. (2000) Anaphase spindle position is monitored by the BUB2 checkpoint. Nature Cell Biol. 2, 556558.[CrossRef][Medline]
Farkasovsky, M. & Kuntzel, H. (2001) Cortical Num1p interacts with the dynein intermediate chain Pac1p and cytoplasmic microtubules in budding yeast. J. Cell Biol.
152, 251262.
Furge, K.A., Cheng, Q., Jwa, M., Shin, S., Song, K. & Albright, C.F. (1999) Regions of Byr4, a regulator of septation in fission yeast, that bind Spg1 or Cdc16 and form a two-component GTPase-activating protein with Cdc16. J. Biol. Chem.
274, 1133911343.
Furge, K.A., Wong, K., Armstrong, J., Balasubramanian, M. & Albright, C.F. (1998) Byr4 and Cdc16 form a two-component GTPase-activating protein for the Spg1 GTPase that controls septation in fission yeast. Curr. Biol. 8, 947954.[CrossRef][Medline]
Garvik, B., Carson, M. & Hartwell, L. (1995) Single-stranded DNA arising at telomeres in cdc13 mutants may constitute a specific signal for the RAD9 checkpoint. Mol. Cell. Biol. 15, 61286138.[Abstract]
Geymonat, M., Spanos, A., Smith, S.J., et al. (2002) Control of mitotic exit in budding yeast: In vitro regulation of Tem1 GTPase by Bub2 and Bfa1. J. Biol. Chem.
277, 2843928445.
Geymonat, M., Spanos, A., Walker, P.A., Johnston, L.H. & Sedgwick, S.G. (2003) In vitro regulation of budding yeast Bfa1/Bub2 GAP activity by Cdc5. J. Biol. Chem.
278, 1459114594.
Gyuris, J., Golemis, E., Chertkov, H. & Bren, R. (1993) Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75, 791803.[CrossRef][Medline]
Hoyt, M.A. (2000) Exit from mitosis: spindle pole power. Cell 102, 267270.[CrossRef][Medline]
Hu, F., Wang, Y., Liu, D., Li, Y., Qin, J. & Elledge, S.J. (2001) Regulation of the Bub2/Bfa1 GAP complex by Cdc5 and cell cycle checkpoints. Cell 107, 655665.[CrossRef][Medline]
Hwang, H.S. & Song, K. (2002) IBD2 encodes a novel component of the Bub2p-dependent spindle checkpoint in the budding yeast Saccharomyces cerevisiae. Genetics
161, 595609.
Janke, C., Ortiz, J., Tanaka, T.U., Lechne, J. & Schiebel, E. (2002) Four new subunits of the Dam1-Duo1 complex reveal novel functions in sister kinetochore biorientation. EMBO J. 21, 181193.[CrossRef][Medline]
Jaspersen, S.L., Charles, J.F. & Morga, D.O. (1999) Inhibitory phosphorylation of the APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14. Curr. Biol. 9, 227236.[CrossRef][Medline]
Jwa, M., Shin, S., Albright, C.F. & Song, K. (1999) Byr4p, a possible regulator of mitosis and cytokinesis in fission yeast, localizes to the spindle pole body by its C-terminal domains. J. Biochem. Mol. Biol. 32, 9297.
Jwa, M. & Song, K. (1998) Byr4, a dosage-dependent regulator of cytokinesis in S. pombe, interacts with a possible small GTPase pathway including Spg1 and Cdc16. Mol. Cells 8, 240245.[Medline]
Knapp, D., Bhoite, L., Stillman, D.J. & Nasmyth, K. (1996) The transcription factor Swi5 regulates expression of the cyclin kinase inhibitor p40Sic1. Mol. Cell. Biol. 16, 57015707.[Abstract]
Korinek, W.S., Copeland, M.J., Chaudhuri, A. & Chan, J. (2000) Molecular linkage underlying microtubule orientation toward cortical sites in yeast. Science
287, 22572259.
Lee, S.E., Frenz, L.M., Wells, N.J., Johnso, A.L. & Johnston, L.H. (2001) Order of function of the budding-yeast mitotic exit-network proteins Tem1, Cdc15, Mob1, Dbf2, and Cdc5. Curr. Biol. 11, 784788.[CrossRef][Medline]
Lee, J., Hwang, H.S., Kim, J. & Song, K. (1999) Ibd1p, a possible spindle pole body associated protein, regulates nuclear division and bud separation in Saccharomyces cerevisiae. Biochim. Biophys. Acta 1449, 239253.[Medline]
Li, R. (1999) Bifurcation of the mitotic checkpoint pathway in budding yeast. Proc. Natl. Acad. Sci. USA
96, 49894894.
Li, Y., Bachant, J., Alcasabas, A.A., Wang, Y., Qin, J. & Elledge, S.J. (2002) The mitotic spindle is required for loading of the DASH complex onto the kinetochore. Genes Dev.
16, 183197.
Liakopoulos, D., Kusch, J., Grava, S., Vogel, J. & Barral, Y. (2003) Asymmetric loading of Kar9 onto spindle poles and microtubules ensures proper spindle alignment. Cell 112, 561574.[CrossRef][Medline]
Longtine, M.S., McKenzie, A., 3rd, Demarini, D.J. , et al. (1998) Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14, 953961.[CrossRef][Medline]
Maekawa, H., Usui, T., Knop, M. & Schiebel, E. (2003) Yeast Cdk1 translocates to the plus end of cytoplasmic microtubules to regulate bud cortex interactions. EMBO J. 22, 438449.[CrossRef][Medline]
McCollum, D. & Gould, K.L. (2001) Timing is everything: regulation of mitotic exit and cytokinesis by the MEN and SIN. Trends Cell Biol. 11, 8995.[CrossRef][Medline]
Morgan, D.O. (1999) Regulation of the APC and the exit from mitosis. Nature Cell Biol. 1, E47E53.[CrossRef][Medline]
Pereira, G., Hofken, T., Grindlay, J., Manson, C. & Schiebel, E. (2000) The Bub2p spindle checkpoint links nuclear migration with mitotic exit. Mol. Cell 6, 110.[CrossRef][Medline]
Pereira, G., Tanaka, T.U., Nasmyth, K. & Schiebel, E. (2001) Modes of spindle pole body inheritance and segregation of the Bfa1p-Bub2p checkpoint protein complex. EMBO J. 20, 63596370.[CrossRef][Medline]
Ro, H.S., Song, S. & Le, K.S. (2002) Bfa1 can regulate Tem1 function independently of Bub2 in the mitotic exit network of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA
99, 54365441.
Sambrook, J. & Russell, D.W. (2001) Molecular Cloning: a Laboratory Manual, 3rd edn. Cold Spring Harbor, N.Y: Cold Spring. Harbor Laboratory Press.
Schwab, M., Lutum, A.S. & Seufert, W. (1997) Yeast Hct1 is a regulator of Clb2 cyclin proteolysis. Cell 90, 683693.[CrossRef][Medline]
Segal, M. & Bloom, K. (2001) Control of spindle polarity and orientation in Saccharomyces cerevisiae. Trends Cell Biol. 11, 160166.[CrossRef][Medline]
Shou, W., Seol, J.H., Shevchenko, A., et al. (1999) Exit from mitosis is triggered by Tem1-dependent release of the protein phosphatase Cdc14 from nucleolar RENT complex. Cell 97, 233244.[CrossRef][Medline]
Song, K., Mach, K.E., Chen, C.Y., Reynold, T. & Albright, C.F. (1996) A novel suppressor of ras1 in fission yeast, byr4, is a dosage-dependent inhibitor of cytokinesis. J. Cell Biol.
133, 13071319.
Visintin, R., Craig, K., Hwang, E.S., Prinz, S., Tyers, M. & Amon, A. (1998) The phosphatase Cdc14 triggers mitotic exit by reversal of Cdk-dependent phosphorylation. Mol. Cell 2, 709718.[CrossRef][Medline]
Visintin, R., Hwang, E.S. & Amon, A. (1999) Cfi1 prevents premature exit from mitosis by anchoring Cdc14 phosphatase in the nucleolus. Nature 398, 818823.[CrossRef][Medline]
Wang, Y., Hu, F. & Elledge, S.J. (2000) The Bfa1/Bub2 GAP complex comprises a universal checkpoint required to prevent mitotic exit. Curr. Biol. 10, 13791382.[CrossRef][Medline]
Zachariae, W., Schwab, M., Nasmyth, K. & Seufert, W. (1998) Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex. Science
282, 17211724.
Received: 3 September 2003
Accepted: 3 February 2004
This article has been cited by other articles:
![]() |
J. Kim, S. S. Jang, and K. Song Different Levels of Bfa1/Bub2 GAP Activity Are Required to Prevent Mitotic Exit of Budding Yeast Depending on the Type of Perturbations Mol. Biol. Cell, October 1, 2008; 19(10): 4328 - 4340. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |